BIO supply chain intelligence for Bio-Rad Laboratories, Inc.: verified suppliers, customers, debt relationships, acquisitions, and ownership data.
Data compiled by Redley Lamar · ChainSifter Intelligence
Bio-Rad Laboratories, Inc. (BIO) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
| Ticker | Name | Confidence | Evidence |
|---|---|---|---|
| HBIO | Harvard Bioscience, Inc. | 72% | Reciprocal relationship from HBIO graph: Reciprocal relationship from BIO graph: Reciprocal relationship from HBIO graph: nt, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Danaher Corpor… |
| IMDX | Insight Molecular Diagnostics Inc. | 72% | Reciprocal relationship from IMDX graph: s to raise capital to finance its operations. Item 1. Business. Overview We are a pioneering diagnostics technology company. Our mission is to democratize acc… |
| MXCT | MaxCyte, Inc. | 72% | Reciprocal relationship from MXCT graph: doption of our products. If these KOLs, institutions and companies do not adopt our products for any reason, including those listed above, acceptance and adop… |
| QGEN | Qiagen N.V. | 72% | Reciprocal relationship from QGEN graph: . Royalty expense is primarily recorded in cost of sales, with a small portion recorded as research and development expense depending on the use of the techno… |
| RENXF | RENXF | 72% | Reciprocal relationship from RENXF graph: in Medicare and other healthcare funding and otherwise affect the price of KidneyIntelX and any diagnostic product for which we may obtain regulatory approva… |
| RNLXY | Renalytix Plc | 72% | Reciprocal relationship from RNLXY graph: Reciprocal relationship from BIO graph: Reciprocal relationship from RNLXY graph: Reciprocal relationship from BIO graph: Reciprocal relationship from RNLXY … |
| DYN | Dyne Therapeutics, Inc. | 62% | Reciprocal relationship from DYN graph: Reciprocal relationship from BIO graph: Reciprocal relationship from DYN graph: Reciprocal relationship from BIO graph: Reciprocal relationship from DYN graph:… |
| Ticker | Name | Confidence | Evidence |
|---|---|---|---|
| USGOV-DEPARTMENT-OF-AGRICULTURE | USGOV-DEPARTMENT-OF-AGRICULTURE | 95% | USAspending awards from Department of Agriculture: $464,998 across 4 awards. 123A9423F0161 DELIVERY ORDER FOR IQ-CHECK KITS UNDER CONTRACT 123A9419D0001 WITH BIO-RAD LABORATORIES INC.; 123A9424F0026 … |
| USGOV-DEPARTMENT-OF-COMMERCE | USGOV-DEPARTMENT-OF-COMMERCE | 95% | USAspending awards from Department of Commerce: $207,100 across 1 awards. 1333ND23PNB640547 BIORAD QX600 AUTODG DROPLET DIGITAL PCR SYSTEM | Qwen corrected direction: Explicit government contract awa… |
| USGOV-DEPARTMENT-OF-DEFENSE | USGOV-DEPARTMENT-OF-DEFENSE | 95% | USAspending awards from Department of Defense: $171,511 across 1 awards. N6600125P6397 QX600 AUTODG DROPLET PCR SYSTEM | Qwen corrected direction: Explicit Department of Defense government contract a… |
| USGOV-DEPARTMENT-OF-HEALTH-AND-HUMAN-SERVICES | USGOV-DEPARTMENT-OF-HEALTH-AND-HUMAN-SERVICES | 95% | USAspending awards from Department of Health and Human Services: $341,214 across 2 awards. 75D30124P19851 PURCHASE OF BIO-RAD OPUS INSTRUMENTS; 75N98019P03259 YEARLY SERVICE MAINTENANCE CONTRACT FOR … |
| USGOV-DEPARTMENT-OF-THE-INTERIOR | USGOV-DEPARTMENT-OF-THE-INTERIOR | 95% | USAspending awards from Department of the Interior: $110,884 across 1 awards. 140D0426P0119 (1) BIO-RAD AUTOMATIC DROPLET GENERATOR (ADG S/N# 773BR3501) AND ONE (1) QX600 DROPLET READER | Qwen correc… |
| USGOV-DEPARTMENT-OF-VETERANS-AFFAIRS | USGOV-DEPARTMENT-OF-VETERANS-AFFAIRS | 95% | USAspending awards from Department of Veterans Affairs: $396,950 across 1 awards. 36C26225P0701 IMMUNOLOGY | Qwen corrected direction: Explicit USAspending awards from Department of Veterans Affairs … |
| HBIO | Harvard Bioscience, Inc. | 72% | Reciprocal relationship from HBIO graph: nt activities to advance our position in the industry as a provider of life science equipment, software and services. We plan to pursue a balanced development… |
| IMDX | Insight Molecular Diagnostics Inc. | 72% | Reciprocal relationship from IMDX graph: Reciprocal relationship from BIO graph: Reciprocal relationship from IMDX graph: Reciprocal relationship from BIO graph: Reciprocal relationship from IMDX gra… |
| MXCT | MaxCyte, Inc. | 72% | Reciprocal relationship from MXCT graph: Reciprocal relationship from BIO graph: Reciprocal relationship from MXCT graph: doption of our products. If these KOLs, institutions and companies do not ado… |
| RENXF | RENXF | 72% | Reciprocal relationship from RENXF graph: Reciprocal relationship from BIO graph: Reciprocal relationship from RENXF graph: in Medicare and other healthcare funding and otherwise affect the price of … |
| ACQUISITIONS-STILLA-TECHNOLOGIES | ACQUISITIONS-STILLA-TECHNOLOGIES | 62% | ome (loss). Warranty liabilities are included in Other current liabilities and Other long-term liabilities in the condensed consolidated balance sheets. Changes in our warranty liability for the thre… |
| STILLA-TECHNOLOGIES | STILLA-TECHNOLOGIES | 62% | ome (loss). Warranty liabilities are included in Other current liabilities and Other long-term liabilities in the condensed consolidated balance sheets. Changes in our warranty liability for the thre… |
| Instrument | Description | Confidence | Evidence |
|---|---|---|---|
| BIO-DEBT | Debt stack $1.4B | 90% | Market cache reports total debt of $1.4B. |
| Holder | Name | Confidence | Evidence |
|---|---|---|---|
| BIO-OWNER-FIRST-EAGLE-INVESTMENT-MANAGEMEN | First Eagle Investment Management, LLC | 90% | 13F overlay lists First Eagle Investment Management, LLC as top holder; 395 tracked holders. |
| Ticker | Name | Chain Index | Hops | Relationship Types |
|---|---|---|---|---|
| DTIL | Precision BioSciences, Inc. | 100.00 | 2 | |
| DYN | Dyne Therapeutics, Inc. | 100.00 | 1 | ['supplier'] |
| TMO | Thermo Fisher Scientific Inc. | 100.00 | 2 | |
| MXCT | MaxCyte, Inc. | 100.00 | 1 | ['customer', 'supplier'] |
| RNLXY | Renalytix Plc | 100.00 | 1 | ['supplier'] |
| HBIO | Harvard Bioscience, Inc. | 100.00 | 1 | ['customer', 'supplier'] |
| QGEN | Qiagen N.V. | 100.00 | 1 | ['supplier'] |
| RENXF | Renalytix plc | 100.00 | 1 | ['customer', 'supplier'] |
| IMDX | Insight Molecular Diagnostics Inc. | 100.00 | 1 | ['customer', 'supplier'] |
| JNJ | Johnson & Johnson | 100.00 | 2 | |
| TGTX | TG Therapeutics, Inc. | 100.00 | 2 | |
| BDX | Becton, Dickinson and Company | 100.00 | 2 | |
| ELV | Elevance Health, Inc. | 50.00 | 2 | |
| CELG-RI | BRISTOL MYERS SQUIBB CO | 50.00 | 2 | |
| ARWR | Arrowhead Pharmaceuticals, Inc. | 50.00 | 2 | |
| ABT | Abbott Laboratories | 50.00 | 2 | |
| CPRX | Catalyst Pharmaceuticals, Inc. | 50.00 | 2 | |
| SRRK | Scholar Rock Holding Corporation | 50.00 | 2 | |
| CRS | Carpenter Technology Corporation | 50.00 | 2 | |
| MANU | Manchester | 50.00 | 2 |